|

Soquelitinib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CPI-818

Pipeline

Phase 3: 1

Top Sponsors

  • Corvus Pharmaceuticals, Inc.1

Indications

  • Lymphoma, T-Cell1
  • Lymphoma, T-Cell, Peripheral1
  • Systemic Anaplastic Large Cell Lymphoma1
  • Nodal Peripheral T-Cell Lymphoma With TFH Phenotype1
  • Follicular T-Cell Lymphoma1

Duarte, California1 trial

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

City of Hope National Medical Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.